S&P 500 7,764.70 +1.49%
Nasdaq 27,122.09 +2.26%
S&P/TSX 36,009.40 +0.57%
Apple 338.98 +0.85%
Nvidia 227.38 +2.30%
Microsoft 501.61 +1.59%
Shopify 193.38 +7.83%
Royal Bank 289.64 +1.82%
CAD/USD 0.7130 −0.22%
CLOSED · 01:15 ET
Market ClerkRecap
Tue Sep 22 · markets closed1 signal on Sep 21234 insider buys this week · $209.5MCIRO short report next: Sep 29The week ahead
QP
INSIDER · ORKA · Oruka Therapeutics, Inc. · GENERAL COUNSEL

Quinlan Paul T

Every open-market transaction filed under this name, Sep 15 to Sep 21.

Filings
5
0 buys · 5 sells
Bought
open market, at cost
Sold
$1M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 21ORKAOruka Therapeutics, Inc.General CounselSell2,667$95.31$254K+2.5%
Sep 21ORKAOruka Therapeutics, Inc.General CounselSell601$94.44$57K+3.5%
Sep 21ORKAOruka Therapeutics, Inc.General CounselSell3,832$93.32$358K+4.7%
Sep 21ORKAOruka Therapeutics, Inc.General CounselSell2,900$92.37$268K+5.8%
Sep 15ORKAOruka Therapeutics, Inc.General CounselSell1,039$95.71$99K+2.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.